The $125 billion question: how will the ACA affect cancer survivors?
In 2010, the total cost of cancer care in the United States reached $125 billion. Cancer patients are also living longer today, which is further increasing the cost of their continued care. As the health insurance exchanges have opened and heated debate about the Affordable Care Act (ACA) continues, many questions remain, including the $125 billion question: “How will the ACA affect the most expensive disease: cancer?”
Integrative health team member highlight: Sue Stella
In many ways, Sue Stella, D.P.T., helps give patients and survivors back certain aspects of their lives that cancer took. In this month's team member highlight, Sue describes her role as a physical therapist and how she loves helping patients set and meet goals that get them as close as possible to their lives before cancer.
International study led by Massey researcher finds promise in new class of anti-cancer drugs
A new class of platinum-based drugs has shown significant anti-metastatic effects in fighting cancer, according to a recently published study led by a Virginia Commonwealth University chemistry professor and Massey researcher.
The aroma of good health
Aroma, the word alone brings powerful memories—some good, some not so good. Most people, however, have no idea how much aroma and our sense of smell can influence well-being. Enter aromatherapy.
Lee studies the role of enzymes in immune response to cancer cells developed from conception
VCU Massey Cancer Center researcher Eun Lee, Ph.D., joined Massey as a member of the Cancer Molecular Genetics research program in 2015. She previously joined the faculty at the VCU School of Medicine in 2014 as an assistant professor of Obstetrics and Gynecology as well as an affiliate faculty member in the Department of Microbiology and Immunology.
Massey researcher awarded $25.2 million to lead a national clinical trial for veterans with lung cancer
VCU Massey Cancer Center physician-researcher Drew Moghanaki, M.D., M.P.H., was awarded $25.2 million from the Veterans Health Administration to lead a national study on an alternative treatment for lung cancer, the deadliest form of cancer.